Literature DB >> 30072742

Analysis of fetal DNA in maternal plasma with markers designed for forensic DNA mixture resolution.

Amandine Moriot1, Diana Hall2.   

Abstract

PURPOSE: With the description of circulating fetal DNA in maternal blood, noninvasive prenatal diagnostics became theoretically possible. As the presence of background maternal DNA interferes with the detection of fetal DNA, analytical methods require genetic markers capable of distinguishing by quantitative or targeted approaches the minor population of DNA molecules of the fetus. Here we evaluate the feasibility of analyzing fetal DNA with novel DIP-STR genetic markers, designed for the investigation of forensic mixed biological evidence.
METHODS: The DIP-STR molecular approach is based on sequence-specific analysis of paternally inherited fetal alleles. These sequences are biallelic deletion/insertion polymorphisms (DIPs) located very close to short tandem repeat (STR) markers, for combined analysis. In this study, 48 women were tested with 28 DIP-STRs during the first, second, and third trimester of pregnancy.
RESULTS: Positive results were obtained across markers, including longer ones (386 base-pairs) and with blood samples collected during early pregnancy, such as 10 weeks of gestational age.
CONCLUSION: These data show that DIP-STR markers can be used to amplify specific genomic regions of circulating fetal DNA to obtain targeted genetic information. This method may contribute to developments in noninvasive prenatal paternity testing and diagnosis of certain genetic diseases.

Entities:  

Keywords:  Cell-free DNA; DIP-STR; DNA mixture; Noninvasive prenatal testing; Paternity testing

Mesh:

Substances:

Year:  2018        PMID: 30072742     DOI: 10.1038/s41436-018-0102-9

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  4 in total

1.  Noninvasive prenatal exclusion of congenital adrenal hyperplasia by maternal plasma analysis: a feasibility study.

Authors:  Rossa W K Chiu; Tze K Lau; Pik T Cheung; Zhi Q Gong; Tse N Leung; Y M Dennis Lo
Journal:  Clin Chem       Date:  2002-05       Impact factor: 8.327

2.  Quantitative abnormalities of fetal DNA in maternal serum in preeclampsia.

Authors:  Y M Lo; T N Leung; M S Tein; I L Sargent; J Zhang; T K Lau; C J Haines; C W Redman
Journal:  Clin Chem       Date:  1999-02       Impact factor: 8.327

3.  Increased fetal DNA concentrations in the plasma of pregnant women carrying fetuses with trisomy 21.

Authors:  Y M Lo; T K Lau; J Zhang; T N Leung; A M Chang; N M Hjelm; R S Elmes; D W Bianchi
Journal:  Clin Chem       Date:  1999-10       Impact factor: 8.327

4.  DIP-STR: highly sensitive markers for the analysis of unbalanced genomic mixtures.

Authors:  Vincent Castella; Joëlle Gervaix; Diana Hall
Journal:  Hum Mutat       Date:  2013-03-05       Impact factor: 4.878

  4 in total
  4 in total

1.  Noninvasive Prenatal Paternity Testing with a Combination of Well-Established SNP and STR Markers Using Massively Parallel Sequencing.

Authors:  Xuefeng Shen; Ran Li; Haixia Li; Yu Gao; Hui Chen; Ning Qu; Dan Peng; Riga Wu; Hongyu Sun
Journal:  Genes (Basel)       Date:  2021-03-22       Impact factor: 4.096

2.  Set of 15 SNP-SNP Markers for Detection of Unbalanced Degraded DNA Mixtures and Noninvasive Prenatal Paternity Testing.

Authors:  Rangran Zhang; Yu Tan; Li Wang; Hui Jian; Jing Zhu; Yuanyuan Xiao; Mengyu Tan; Jiaming Xue; Fan Yang; Weibo Liang
Journal:  Front Genet       Date:  2022-02-10       Impact factor: 4.599

Review 3.  Application of Y-STR, DIP-STR and SNP-STR Markers in Interpretation of Forensic Genetic Profiling: A Narrative Review.

Authors:  Mehdi Forouzesh; Shiva Irani; Azam Soleimani; Seyed Jalil Monabati
Journal:  Iran J Public Health       Date:  2022-07       Impact factor: 1.479

4.  Multi-Indel: A Microhaplotype Marker Can Be Typed Using Capillary Electrophoresis Platforms.

Authors:  Shengqiu Qu; Meili Lv; Jiaming Xue; Jing Zhu; Li Wang; Hui Jian; Yuqing Liu; Ranran Zhang; Lagabaiyila Zha; Weibo Liang; Lin Zhang
Journal:  Front Genet       Date:  2020-10-23       Impact factor: 4.599

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.